Neurotensin: a neuropeptide induced by hCG in the human and rat ovary during the periovulatory period†.
cumulus oocyte complex
fertility
granulosa cell
neurotensin
ovary
ovulation
Journal
Biology of reproduction
ISSN: 1529-7268
Titre abrégé: Biol Reprod
Pays: United States
ID NLM: 0207224
Informations de publication
Date de publication:
04 06 2021
04 06 2021
Historique:
received:
19
11
2020
revised:
04
02
2021
accepted:
02
03
2021
pubmed:
9
3
2021
medline:
4
1
2022
entrez:
8
3
2021
Statut:
ppublish
Résumé
Neurotensin (NTS) is a tridecapeptide that was first characterized as a neurotransmitter in neuronal cells. The present study examined ovarian NTS expression across the periovulatory period in the human and the rat. Women were recruited into this study and monitored by transvaginal ultrasound. The dominant follicle was surgically excised prior to the luteinizing hormone (LH) surge (preovulatory phase) or women were given 250 μg human chorionic gonadotropin (hCG) and dominant follicles collected 12-18 h after hCG (early ovulatory), 18-34 h (late ovulatory), and 44-70 h (postovulatory). NTS mRNA was massively induced during the early and late ovulatory stage in granulosa cells (GCs) (15 000 fold) and theca cells (700 fold). In the rat, hCG also induced Nts mRNA expression in intact ovaries and isolated GCs. In cultured granulosa-luteal cells (GLCs) from IVF patients, NTS expression was induced 6 h after hCG treatment, whereas in cultured rat GCs, NTS increased 4 h after hCG treatment. Cells treated with hCG signaling pathway inhibitors revealed that NTS expression is partially regulated in the human and rat GC by the epidermal-like growth factor pathway. Human GLC, and rat GCs also showed that Nts was regulated by the protein kinase A (PKA) pathway along with input from the phosphotidylinositol 3- kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways. The predominat NTS receptor present in human and rat GCs was SORT1, whereas NTSR1 and NTSR2 expression was very low. Based on NTS actions in other systems, we speculate that NTS may regulate crucial aspects of ovulation such as vascular permeability, inflammation, and cell migration.
Identifiants
pubmed: 33682882
pii: 6158009
doi: 10.1093/biolre/ioab036
pmc: PMC8485077
doi:
Substances chimiques
Chorionic Gonadotropin
0
Neurotensin
39379-15-2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1337-1346Subventions
Organisme : NICHD NIH HHS
ID : P01 HD071875
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD097675
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Comp Neurol. 2003 Jul 7;461(4):520-38
pubmed: 12746866
J Biol Chem. 2011 Jan 7;286(1):542-54
pubmed: 21030593
JAMA. 1989 Oct 6;262(13):1808-14
pubmed: 2674487
Biol Reprod. 2014 Aug;91(2):53
pubmed: 25031361
Eur J Pharmacol. 2015 Sep 5;762:184-92
pubmed: 26004530
J Neurosci. 2003 Feb 15;23(4):1198-205
pubmed: 12598608
Endocrinology. 2011 Jun;152(6):2416-27
pubmed: 21467196
Am J Surg Pathol. 1984 May;8(5):345-56
pubmed: 6203413
J Clin Endocrinol Metab. 2017 Jun 1;102(6):1971-1982
pubmed: 28323945
Nature. 2016 May 11;533(7603):411-5
pubmed: 27193687
BMC Syst Biol. 2018 Apr 3;12(1):36
pubmed: 29615037
Mol Cell Biol. 2008 Mar;28(5):1770-82
pubmed: 18172011
Oncotarget. 2014 Sep 30;5(18):8252-69
pubmed: 25249545
Endocrinology. 1989 Feb;124(2):783-8
pubmed: 2912701
Endocrinology. 2015 Sep;156(9):3358-69
pubmed: 26125463
J Exp Biol. 1980 Dec;89:193-200
pubmed: 6162907
Neuroendocrinology. 1982 Feb;34(2):95-8
pubmed: 7070589
Acta Biochim Biophys Sin (Shanghai). 2008 May;40(5):426-36
pubmed: 18465028
J Clin Endocrinol Metab. 2011 Apr;96(4):1021-8
pubmed: 21252246
Behav Sci (Basel). 2014 Jun 13;4(2):125-53
pubmed: 25379273
Eur J Pharmacol. 2013 Sep 15;716(1-3):54-60
pubmed: 23500196
Eur J Pharmacol. 2016 May 5;778:96-102
pubmed: 25941080
Clin Exp Pharmacol Physiol. 2017 Aug;44(8):841-846
pubmed: 28556374
Biol Reprod. 1998 Nov;59(5):1077-83
pubmed: 9780312
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E7049-E7058
pubmed: 27663735
Endocrinology. 2018 Jun 1;159(6):2447-2458
pubmed: 29648638
J Neurosci. 1998 Sep 1;18(17):6672-80
pubmed: 9712639
Biol Reprod. 2013 Nov 21;89(5):121
pubmed: 24048576
Endocrinology. 2018 Feb 1;159(2):710-722
pubmed: 29095972
Reproduction. 2006 Oct;132(4):571-7
pubmed: 17008468
J Pathol. 2019 Jul;248(3):352-362
pubmed: 30883751
Trends Endocrinol Metab. 1991 Nov-Dec;2(6):233-9
pubmed: 18411188
Ann N Y Acad Sci. 1982;400:1-16
pubmed: 6963107
Eur J Neurosci. 2019 Mar;49(6):784-793
pubmed: 29405480
Sci Rep. 2015 Jun 08;5:10775
pubmed: 26053859
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Neuroendocrinology. 1984 Feb;38(2):145-51
pubmed: 6717745
Front Pharmacol. 2019 Jan 07;9:1507
pubmed: 30666202
Mol Endocrinol. 2006 Jun;20(6):1352-65
pubmed: 16543407
J Comp Neurol. 1994 Jul 22;345(4):496-509
pubmed: 7962697
Acta Obstet Gynecol Scand. 2006;85(12):1476-84
pubmed: 17260225
Clin Obstet Gynecol. 1996 Jun;39(2):486-97
pubmed: 8734013
J Neurosci Res. 2004 Oct 1;78(1):92-9
pubmed: 15372498
J Comp Neurol. 2003 Jul 7;461(4):483-505
pubmed: 12746864
Hum Reprod. 2014 May;29(5):997-1010
pubmed: 24510971
Regul Pept. 2011 Oct 10;170(1-3):7-17
pubmed: 21549161
Cancer. 1982 Jan 1;49(1):68-74
pubmed: 6119150
Mol Hum Reprod. 2006 Dec;12(12):725-36
pubmed: 17071711
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4241-4252
pubmed: 30124866
Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E80-8
pubmed: 19861584